S10.AI

The generated artifacts across all modules are model output: the note, the code suggestions, the phone conversation and the chart audit. Worth separating one thing that is often conflated in its marketing: the integration reach comes from robotic process automation, which is scripted automation rather than intelligence, so the breadth claim and the AI claim rest on different technology.

Several autonomous surfaces, none with published limits. CRUSH delivers billing ready codes into the record. BRAVO answers every call, books, reschedules and cancels directly in the EHR, handles refill requests and prior authorisation follow ups, and triages symptoms with what the vendor calls clinical guardrails without describing what they are. SHINE flags where revenue is being left on the table. No confidence threshold, escalation path, abstention behaviour or accuracy figure is published for any of them, and symptom triage by an autonomous phone agent is the same undisclosed escalation problem this index graded C for Hello Patient in the voice lane.

Mixed. The integration architecture is disclosed unusually specifically, as server side robotic process automation rather than vague talk of connectivity, and that is a genuine technical statement a buyer can evaluate. Against that, the performance claims are unsubstantiated and internally inconsistent: 99 percent transcription accuracy with no methodology or reference standard, 95 percent of documentation automated, 75 percent faster charting, and language coverage stated as 16 or more in some materials and 60 or more in others. No model card, named models or evaluation protocol was located.

No peer reviewed study, controlled evaluation, third party performance rating or named health system outcome data located. Claims are vendor generated and supported by physician testimonials. A specific caution applies to sourcing here: much of the comparative material about this vendor appearing in search results is published by S10.AI itself in the form of competitor rankings and pricing comparisons, which is the self interested source pattern this index already flags for Mentalyc and Ordr. Use it for the vendor's own product claims and nothing else.

ISO 27001 certification and compliance claims across HIPAA, PIPEDA and GDPR give this more substance than most at this price point. One architectural consequence deserves specific diligence rather than assumption: robotic process automation drives the EHR through its interface, which generally means the system authenticates and acts within the record environment on the clinician's behalf. Establish whose credentials it uses, how they are stored, and how its actions appear in the EHR audit log, because a bot operating under a named user's identity makes access logs harder to interpret. No retention schedule or training use statement was located.

Claims compliance across three regimes, HIPAA, PIPEDA and GDPR, which is broader regulatory coverage than most vendors at this price point attempt. Specific business associate agreement terms are not published for inspection before contracting.

ISO 27001 certification is named, which is a real external audit standard rather than a marketing phrase and puts this ahead of most of the small and mid market vendors in this category. Held at B rather than A because no certification date, scope statement or certificate reference was located, and no SOC 2 Type II report was found, which is the attestation most United States health system security reviews will actually ask for.

Not a regulated medical device and none claimed. Note that autonomous symptom triage over the phone sits closer to regulated territory than documentation does, and the classification question is worth raising given BRAVO's described scope.

Two governance relevant designs, no governance disclosure. SHINE explicitly audits notes to flag missed HCC and CDI revenue, which carries the same coding gradient this index graded down for Charta Health and Solventum, though framed as compliance audit rather than revenue optimisation and therefore milder than MarianaAI. BRAVO performs symptom triage under undefined clinical guardrails. Against both, no fairness statement, subgroup analysis or accent and dialect performance disclosure was located, despite a marketed language range in the dozens.

Broad reach achieved by a structurally different route, and the difference matters more than the number. Rather than building API integrations, S10.AI uses server side robotic process automation to operate the record system through its own interface, which is why it can claim more than 100 EHRs including legacy and non standard platforms such as Practice Fusion and OpenEMR that larger vendors decline to support, and why it can add an unsupported system in roughly two weeks. For a solo or small practice on an obscure EHR this is genuinely the widest door in the category. But RPA is not equivalent to native integration: it depends on the interface staying where it was, is more brittle across vendor updates, and reads and writes as a user rather than through a sanctioned data channel. Graded B on reach with that architecture stated plainly rather than penalised.

Not assessed. Cloud delivered with iOS and Android clients, but no hosting region, residency option or sub processor detail was located.

Publishes a flat rate prominently and builds its market positioning on it: 99 US dollars per provider per month, with no enterprise gate and no quote required, explicitly aimed at clinicians priced out of enterprise contracts. In a category where most vendors publish nothing and buyers cannot compare quotes, a public flat rate is the strongest form of commercial transparency and it is doing competitive work rather than sitting in a footnote. One thing to confirm at contracting, because the vendor markets five products on one contract: exactly which modules the flat rate includes and which are additional.

Broad in claim and thin in enumeration. Positioned across any specialty with specialty specific templates, covering in person, telehealth and chat encounters, and sold from solo practitioners through to enterprises, with chronic care and remote monitoring billing capture included. Language coverage is claimed but stated inconsistently across the vendor's own materials, which is exactly the kind of detail a multi language buyer needs settled before contracting.